rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Richard B. Slansky

Chief Financial Officer

Company insider

Files Form 4 as: Chief Financial Officer, Genenta Science S.p.A; Chief Financial Officer, Oncosec Medical; Chief Financial Officer, GenMark Diagnostics; Chief Financial Officer, Digirad; President and CFO, Spacedev.

Every Form 4 they filed

In numbers

Trades disclosed
88
Buys
2
Sells
15
Bought
$1.0M
Sold
$178K
Companies
5
Companies where not an officer
0
First trade
1 May 2006
Last trade
30 Mar 2026
Last filed
1 Apr 2026

Companies traded

Where they are an officer
GNTA Genenta Science S.p.AOfficer · Biotechnology · last 30 Mar 20260 buys · 0 sells
Oncosec MedicalOfficer · last 5 Jul 20181 buy · 11 sells
GenMark DiagnosticsOfficer · last 8 May 20141 buy · 4 sells
DigiradOfficer · last 10 Apr 20120 buys · 0 sells
SpacedevDirector, Officer · last 21 Apr 20080 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
30 Mar 2026filed 1 Apr 2026GNTA Genenta Science S.p.Aoption or derivative · BiotechnologySEC FORM 4 Code A—80,000 at $0.00filing
30 Mar 2026filed 1 Apr 2026GNTA Genenta Science S.p.Aoption or derivative · BiotechnologySEC FORM 4 Code A—80,000 at $0.00filing
5 Jul 2018filed 6 Jul 2018Oncosec MedicalSEC FORM 4 Sold$8,8106,725 at $1.31filing
29 Jun 2018filed 6 Jul 2018Oncosec MedicalSEC FORM 4 Sold$3,3402,420 at $1.38filing
28 Jun 2018filed 6 Jul 2018Oncosec MedicalSEC FORM 4 Sold$4,9453,532 at $1.40filing
27 Jun 2018filed 6 Jul 2018Oncosec MedicalSEC FORM 4 Sold$11K7,832 at $1.37filing
26 Jun 2018filed 6 Jul 2018Oncosec MedicalSEC FORM 4 Sold$15K10,673 at $1.40filing
25 Jun 2018filed 6 Jul 2018Oncosec MedicalSEC FORM 4 Sold$646458 at $1.41filing
22 Jun 2018filed 6 Jul 2018Oncosec MedicalSEC FORM 4 Sold$9,5286,710 at $1.42filing
21 Jun 2018filed 6 Jul 2018Oncosec MedicalSEC FORM 4 Sold$6,9224,944 at $1.40filing
20 Jun 2018filed 6 Jul 2018Oncosec MedicalSEC FORM 4 Sold$35K24,906 at $1.42filing
19 Jun 2018filed 6 Jul 2018Oncosec MedicalSEC FORM 4 Sold$5,6734,171 at $1.36filing
18 Jun 2018filed 6 Jul 2018Oncosec MedicalSEC FORM 4 Sold$18K12,613 at $1.39filing
15 Jun 2018filed 6 Jul 2018Oncosec MedicalSEC FORM 4 Code M—100,000filing
15 Jun 2018filed 6 Jul 2018Oncosec MedicalSEC FORM 4 Code M—100,000filing
15 Jun 2018filed 6 Jul 2018Oncosec Medicaloption or derivativeSEC FORM 4 Code M—100,000 at $0.00filing
15 Jun 2018filed 6 Jul 2018Oncosec Medicaloption or derivativeSEC FORM 4 Code M—100,000 at $0.00filing
3 May 2018filed 7 May 2018Oncosec Medicaloption or derivativeSEC FORM 4 Code A$147K100,000 at $1.47filing
12 Jan 2018filed 17 Jan 2018Oncosec Medicaloption or derivativeSEC FORM 4 Code A—100,000 at $0.00filing
29 Mar 2017filed 31 Mar 2017Oncosec Medicaloption or derivativeSEC FORM 4 Code A—100,000 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Not placed17

Buys in green, sells in red, by the company’s sector.

Related people

Pierluigi ParacchiChief Executive Officer · Chief Executive Officer at Genenta Science S.p.A, filing Form 4 there in the last year
Francesco GalimiCMO& Head of Development · CMO& Head of Development at Genenta Science S.p.A, filing Form 4 there in the last year
Armon ShareiDirector · Director at Genenta Science S.p.A, filing Form 4 there in the last year
Miguel Maria MuttiDirector · Director at Genenta Science S.p.A, filing Form 4 there in the last year
Giacomoantonio ParacchiDirector · Director at Genenta Science S.p.A, filing Form 4 there in the last year